Albert de la Chapelle, professor in the department of cancer biology and genetics at Ohio State University, has received a lifetime achievement award from the Collaborative Group of the Americas on Inherited Colorectal Cancer, which was established to improve understanding of inherited colorectal cancer and the clinical management of affected families, particularly those living in the Americas.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
